Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.
Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F. Massimino M, et al. Among authors: riccardi r. J Clin Oncol. 2002 Oct 15;20(20):4209-16. doi: 10.1200/JCO.2002.08.087. J Clin Oncol. 2002. PMID: 12377964 Clinical Trial.
Hypersensitivity reactions to carboplatin in children.
Lazzareschi I, Ruggiero A, Riccardi R, Attinà G, Colosimo C, Lasorella A. Lazzareschi I, et al. Among authors: riccardi r. J Neurooncol. 2002 May;58(1):33-7. doi: 10.1023/a:1015853200090. J Neurooncol. 2002. PMID: 12160138
Interventions for anemia in pediatric cancer patients.
Ruggiero A, Riccardi R. Ruggiero A, et al. Among authors: riccardi r. Med Pediatr Oncol. 2002 Oct;39(4):451-4. doi: 10.1002/mpo.10184. Med Pediatr Oncol. 2002. PMID: 12203662 Review.
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
Cefalo G, Massimino M, Ruggiero A, Barone G, Ridola V, Spreafico F, Potepan P, Abate ME, Mascarin M, Garrè ML, Perilongo G, Madon E, Colosimo C, Riccardi R. Cefalo G, et al. Among authors: riccardi r. Neuro Oncol. 2014 May;16(5):748-53. doi: 10.1093/neuonc/not320. Epub 2014 Jan 30. Neuro Oncol. 2014. PMID: 24482446 Free PMC article. Clinical Trial.
Phase II trial of temozolomide in children with recurrent high-grade glioma.
Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Di Rocco C, Madon E, Abate ME, Clerico A, Sandri A, Riccardi R. Ruggiero A, et al. Among authors: riccardi r. J Neurooncol. 2006 Mar;77(1):89-94. doi: 10.1007/s11060-005-9011-2. J Neurooncol. 2006. PMID: 16292488 Clinical Trial.
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.
Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G. Modena P, et al. Among authors: riccardi r. J Clin Oncol. 2006 Nov 20;24(33):5223-33. doi: 10.1200/JCO.2006.06.3701. J Clin Oncol. 2006. PMID: 17114655
Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings.
Falsini B, Ziccardi L, Lazzareschi I, Ruggiero A, Placentino L, Dickmann A, Liotti L, Piccardi M, Balestrazzi E, Colosimo C, Di Rocco C, Riccardi R. Falsini B, et al. Among authors: riccardi r. J Neurooncol. 2008 May;88(1):87-96. doi: 10.1007/s11060-008-9537-1. Epub 2008 Feb 2. J Neurooncol. 2008. PMID: 18246407
353 results